Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-98-001096
Filing Date
1998-02-06
Accepted
1998-02-06 00:00:00
Documents
2
Group Members
CHANCELLOR LGT ASSET MANAGEMENT INCCHANCELLOR LGT TRUST COMPANYLGT ASSET MANAGEMENT
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 10746
2 IDENTIFICATION AND CLASSIFICATION OF MEMBERS EX-99.I 362
  Complete submission text file 0000950123-98-001096.txt   13356
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 98524288
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEGAL DEPARTMENT 50 CALIFORNIA ST., 24TH FL SAN FRANCISCO CA 94111
Business Address 50 CALIFORNIA ST 27TH FLOOR SAN FRANCISCO CA 94111 4154553313
CHANCELLOR LGT ASSET MANAGEMENT INC (Filed by) CIK: 0000911262 (see all company filings)

EIN.: 942259541 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 0000